Diagnostic and therapeutic approach to pancreatic cancer

Jamie S Barkin, J. A. Goldstein

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Adenocarcinoma of the pancreas ranks fourth as a cause of cancer death in adults in the United States and is the second most common cause of cancer deaths of all GI-related carcinomas. It usually presents late in its course. The clinical features are discussed, with emphasis on those that allow early detection of the disease, as well as a review of diagnostic methods and pre- and perioperative staging, which will allow the appropriate application of surgical and palliative therapeutic modalities. Despite the significant progress that has been made, further research studies are needed to advance our therapeutic approach to this aggressive cancer. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

Original languageEnglish
Pages (from-to)400-409
Number of pages10
JournalBiomedicine and Pharmacotherapy
Volume54
Issue number7
DOIs
StatePublished - Sep 19 2000

Fingerprint

Pancreatic Neoplasms
Cause of Death
Neoplasms
Early Diagnosis
Pancreas
Adenocarcinoma
Therapeutics
Carcinoma
Research

Keywords

  • Adenocarcinoma
  • K-ras gene mutation
  • Pancreas
  • Pancreatitis
  • Unresectable and resectable

ASJC Scopus subject areas

  • Pharmacology

Cite this

Diagnostic and therapeutic approach to pancreatic cancer. / Barkin, Jamie S; Goldstein, J. A.

In: Biomedicine and Pharmacotherapy, Vol. 54, No. 7, 19.09.2000, p. 400-409.

Research output: Contribution to journalArticle

@article{230d5139671d472a94b6972b3c19090f,
title = "Diagnostic and therapeutic approach to pancreatic cancer",
abstract = "Adenocarcinoma of the pancreas ranks fourth as a cause of cancer death in adults in the United States and is the second most common cause of cancer deaths of all GI-related carcinomas. It usually presents late in its course. The clinical features are discussed, with emphasis on those that allow early detection of the disease, as well as a review of diagnostic methods and pre- and perioperative staging, which will allow the appropriate application of surgical and palliative therapeutic modalities. Despite the significant progress that has been made, further research studies are needed to advance our therapeutic approach to this aggressive cancer. (C) 2000 Editions scientifiques et medicales Elsevier SAS.",
keywords = "Adenocarcinoma, K-ras gene mutation, Pancreas, Pancreatitis, Unresectable and resectable",
author = "Barkin, {Jamie S} and Goldstein, {J. A.}",
year = "2000",
month = "9",
day = "19",
doi = "10.1016/S0753-3322(01)80008-1",
language = "English",
volume = "54",
pages = "400--409",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "7",

}

TY - JOUR

T1 - Diagnostic and therapeutic approach to pancreatic cancer

AU - Barkin, Jamie S

AU - Goldstein, J. A.

PY - 2000/9/19

Y1 - 2000/9/19

N2 - Adenocarcinoma of the pancreas ranks fourth as a cause of cancer death in adults in the United States and is the second most common cause of cancer deaths of all GI-related carcinomas. It usually presents late in its course. The clinical features are discussed, with emphasis on those that allow early detection of the disease, as well as a review of diagnostic methods and pre- and perioperative staging, which will allow the appropriate application of surgical and palliative therapeutic modalities. Despite the significant progress that has been made, further research studies are needed to advance our therapeutic approach to this aggressive cancer. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

AB - Adenocarcinoma of the pancreas ranks fourth as a cause of cancer death in adults in the United States and is the second most common cause of cancer deaths of all GI-related carcinomas. It usually presents late in its course. The clinical features are discussed, with emphasis on those that allow early detection of the disease, as well as a review of diagnostic methods and pre- and perioperative staging, which will allow the appropriate application of surgical and palliative therapeutic modalities. Despite the significant progress that has been made, further research studies are needed to advance our therapeutic approach to this aggressive cancer. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

KW - Adenocarcinoma

KW - K-ras gene mutation

KW - Pancreas

KW - Pancreatitis

KW - Unresectable and resectable

UR - http://www.scopus.com/inward/record.url?scp=0033862198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033862198&partnerID=8YFLogxK

U2 - 10.1016/S0753-3322(01)80008-1

DO - 10.1016/S0753-3322(01)80008-1

M3 - Article

C2 - 10989980

AN - SCOPUS:0033862198

VL - 54

SP - 400

EP - 409

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 7

ER -